Research continues to explore the potential of Kyprolis in treating multiple myeloma and possibly other cancers. Ongoing studies aim to optimize dosing regimens, improve patient outcomes, and reduce side effects. Additionally, there is interest in combining Kyprolis with novel agents to further enhance its efficacy and broaden its therapeutic applications.
